Influence of Helicobacter pylori genotype on triple eradication therapy

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 12, 2007, Pages 2251-2555

  Zhao, Jian Jun ^a   Wang, Jiang Bin ^a   Yang, Lei ^a   Li, Yan ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Eradication; Genotype; Helicobacter pylori; Histopathological lesion; Proton pump inhibitor

Indexed keywords

AMOXICILLIN; CAGA PROTEIN; CLARITHROMYCIN; ESOMEPRAZOLE; VACUOLATING TOXIN;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; CONTROLLED STUDY; DENSITY; DRUG TREATMENT FAILURE; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL CHEMOTAXIS; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME; ULCER HEALING;

EID: 36349011803     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.04836.x     Document Type: Article

References (31)

1. Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990 335 : 1233 5.
2. Tytgat GN, Noach LA, Rauws EA. Helicobacter pylori infection and duodenal ulcer disease. Gastroenterol. Clin. North Am. 1993 22 : 127 39.
3. Miehlke S, Bayerdorffer E, Lehn N et al. Recurrence of duodenal ulcers during five years of follow-up after cure of Helicobacter pylori infection. Eur. J. Gastroenterol. Hepatol. 1995 7 : 975 8.
4. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996 110 : 1244 52.
5. Axon AT, O'Morain CA, Bardhan KD et al. Randomized double-blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. Br. Med. J. 1997 314 : 565 8.
6. Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest. Endosc. 1995 41 : 1 4.
7. Macri G, Milani S, Surrenti E, Passaleva MT, Salvadori G, Surrenti C. Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long term follow-up study. Am. J. Gastroenterol. 1998 93 : 925 7.
8. European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997 41 : 8 13.
9. Huang J, Hunt RH. The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. Aliment Pharmacol. Ther. 1999 13 : 719 29.
10. Laheij RJ, Rossum LG, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection: a meta-analysis. Aliment Pharmacol. Ther. 1999 13 : 857 64.
11. Graham DY. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 1998 115 : 1272 7.
12. Houben MH, van de Beek D, Hensen EF, Craen AJ, Rauws EA, Tytgat GN. A systematic review of Helicobacter pylori eradication therapy: the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol. Ther. 1999 13 : 1047 55.
13. van der Hulst RW, Weel JF, Verheul SB et al. Treatment of Helicobacter pylori infection with low or high dose omeprazole combined with amoxycillin and the effect of early retreatment. Aliment Pharmacol. Ther. 1996 10 : 165 71.
14. Labenz J, Leverkus F, Borsch G. Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success. Scand. J. Gastroenterol. 1994 29 : 1070 5.
15. van Doorn LJ, Schneeberger PM, Nouhan N, Plaisier AP, Quint WG, de Boer WA. Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment. Gut 2000 46 : 321 6.
16. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney System. Am. J. Surg. Pathol. 1996 20 : 1161 81.
17. Tummuru MK, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect. Immun. 1993 61 : 1799 809.
18. Owen RJ, Hurtado A, Banatvala N et al. Conservation of the cytotoxin-associated (cagA) gene of Helicobacter pylori and investigation of associated with vacuolating-cytotoxin activity and gastroduodenal disease. FEMS Immunol. Med. Microbiol. 1994 9 : 307 15.
19. Atherton JC, Cao P, Peek RM Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J. Biol. Chem. 1995 270 : 17771 7.
20. Megraud F. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 1998 115 : 1278 82.
21. Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J. Helicobacter pylori CagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996 110 : 1744 52.
22. Matsushima K, Oppenheim JJ. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1989 1 : 2 13.
23. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest 1989 84 : 1045 9.
24. Fox JG, Wang TC. Helicobacter pylori infection: pathogenesis. Curr. Opin. Gastroenterol. 2002 18 : 15 25.
25. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000 287 : 1497 500.
26. Broutet N, Marais A, Liu D et al. CagA negative status: a risk factor for failure of Helicobacter pylori triple therapies in nonulcer dyspepsia. Gut 1998 43 (Suppl. 2 79.
27. Broutet N, Marais A, Lamouliatte H et al. CagA status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia. J. Clin. Microbiol. 2001 39 : 1319 22.
28. McColl KE. Pathophysiology of duodenal ulcer disease. Eur J. Gastroentrol. Hepatol. 1997 9 : S9 12.
29. Alam K, Schubert TT, Bologna SD, Ma CK. Increased density of Helicobacter pylori on antral biopsy is associated with severity of acute and chronic inflammation and likelihood of duodenal ulceration. Am. J. Gastroenterol. 1992 87 : 424 8.
30. Atherton JC, Tham KT, Peek RM Cover TL, Blaser MJ. Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J. Infect. Dis. 1996 174 : 552 6.
31. Maconi G, Parente F, Russo A, Vago L, Imbesi V, Porro GB. Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? Am. J. Gastroenterol. 2001 96 : 359 66.